Navigation Links
Ingenuity Variant Analysis Sees Exponential Customer Adoption
Date:11/6/2012

REDWOOD CITY, Calif., Nov. 6, 2012 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, today highlighted strong adoption of its Variant Analysis platform at the American Society of Human Genetics Annual Meeting in San Francisco. Variant Analysis, a web-based analysis application, answers a critical need for researchers trying to rapidly identify relevant casual variants in human diseases from re-sequencing data.

Over the past 6 months the number of users and samples uploaded into Ingenuity Variant Analysis has grown 250% month-over-month and today 1,100 users are actively working on whole genome and exome projects ranging from individual genomes to thousands of genomes. The users represent over 500 leading institutions and drug discovery companies studying all stages of basic, translational and clinical research.

"All of us need help interpreting DNA sequence variation in the context of the world's literature and rapidly evolving databases," said David M. Margulies, MD, Executive Director, Gene Partnership, Children's Hospital Boston and member of Faculties of Genetics, Bioinformatics, and Developmental Medicine, Harvard Medical School. "Ingenuity's rigorous methods for curating variant information and its deep capabilities in relating sequence and expression data to underlying pathways are invaluable to us as we seek to understand the contribution of sequence variation to disease in both clinical and discovery scenarios."  

"The interpretation of human genomes for medical and biological relevance is a major challenge. Variant Analysis has proven to be a helpful tool to contribute to the interpretation of our exome sequencing-based studies," stated Estelle Chanudet-van den Brink, PhD, Senior Research Associate, GOSgene, University College of London. "We tested it in the context of 9 different rare genetic conditions (73 samples total), including various modes of inheritance. We found the process intuitive and the analytic parameters pragmatically fitted to the diversity of our data. The access to rich biological content, that leverages information on pathways and disease models, was particularly useful to support the prioritization of variants for further analyses. We are now extending the use of Variant Analysis to additional cohorts of patients (250 samples)."

"Increasing access to the unique content and intuitive graphical user interface in Variant Analysis allowed us to quickly identify variants of interest in our sequencing data on muscular dystrophy," said Susan Dorsey, PhD, RN, FAAN, Associate Dean for Research, University of Maryland. "In a matter of hours, we were able to quickly learn how to use the tool and obtain preliminary results. I anticipate that we will be working with the company and its tools for years to come."  

Further, at ASHG this week in San Francisco, attendees will have will have the opportunity to demo Variant Analysis in the Ingenuity booth #1101 or through its integration into third-party applications such as Ion Torrent's Ion Reporter and Illumina's BaseSpace.

About Ingenuity® Systems
Ingenuity® Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems in life science research and molecular diagnostics. Today, Ingenuity's solutions are used by tens of thousands of researchers and clinicians at hundreds of leading pharmaceutical, biotechnology, academic, diagnostic and clinical institutions worldwide.


'/>"/>
SOURCE Ingenuity Systems
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. ShanghaiBio Corporation Partners with Ingenuity Systems to Address Challenges in Analysis and Interpretation of Genomics Data
2. Common genetic variants identify autism risk in high risk siblings of children with ASD
3. Whitehead scientists identify major flaw in standard approach to global gene expression analysis
4. DNA analysis aids in classifying single-celled algae
5. International Life Sciences Conferences Address Advancements in High-Content Analysis, Sample Preparation, Clinical Trial Supply and Protein and Antibody Engineering
6. BGI Tech develops whole exome sequencing analysis of FFPE DNA samples to boost biomedicine
7. Study provides first-time analysis of 3 distinct contributions of forage fish worldwide
8. New method provides fast, accurate, low cost analysis of BRCA gene mutations in breast cancer
9. Wayne State researchers working to improve genetic analysis, disorder detection
10. NCEAS DataONE streamlines search and analysis of massive amounts of ecological data
11. Screening horticultural imports: New models assess plant risk through better analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology: